Pluripotent stem cell-derived cell therapies are accelerating rapidly into clinical trials. The ISSCR, in partnership with Novo Nordisk, is pleased to invite you to Copenhagen, Denmark in October 2024 for an event that will gather pioneers at the forefront of ESC and iPSC-derived cell therapies. Here, world-renowned scientists and innovators will share the latest updates on ongoing clinical trials, as well as groundbreaking platforms and technologies that will revolutionize the next generation of cell therapies for devastating and intractable diseases. Submit an abstract and access early registration rates before 31 July 2024.
Dates: 2-4 October 2024
Times: 9:00 a.m. – 5:00 p.m. CEST
Venue: The Black Diamond – Royal Danish Library, Søren Kierkegaards Plads 1, DK 1221 Copenhagen K
Click here to read more and sign up.
Raise your company’s visibility to industry and academic leaders driving the development ESC/iPSC-derived cell therapies. MVA members receive a 10% discount on all sponsorship items, including brand visibility, receptions with access to key thought leaders, and presentations in the program.
Reach out to exhibits@isscr.org for more information.